• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性短暂性脑缺血发作中的止血标志物。

Hemostatic markers in acute transient ischemic attacks.

作者信息

Fon E A, Mackey A, Côté R, Wolfson C, McIlraith D M, Leclerc J, Bourque F

机构信息

Department of Neurology and Neurosurgery, Montreal General Hospital, McGill University, Quebec, Canada.

出版信息

Stroke. 1994 Feb;25(2):282-6. doi: 10.1161/01.str.25.2.282.

DOI:10.1161/01.str.25.2.282
PMID:8303732
Abstract

BACKGROUND AND PURPOSE

Hemostatic abnormalities have been shown previously in stroke patients. The purpose of this study was to assess the activity of selected parameters of the coagulation system in acute reversible cerebral ischemia.

METHODS

We measured fibrinopeptide A, thrombin-antithrombin III, and D-dimer in 36 patients in both the acute (< 7 days) and postacute stage (1 and 3 months) after a transient ischemic attack (TIA). The results were compared with those of 20 asymptomatic patients with a history of remote TIA and 65 age- and sex-matched controls.

RESULTS

Mean fibrinopeptide A and thrombin-antithrombin III values were elevated in the acute stage after a TIA (P < .02) compared with levels at 1 month. In contrast, D-dimer was significantly increased at all three times points after the event when compared with remote TIA (P < .05) or control subjects (P < .001). No association could be found between marker levels and clinical outcome or the degree of cervical atherosclerosis as assessed by duplex ultrasonography.

CONCLUSIONS

These findings suggest that after acute reversible cerebral ischemia, there is early transient activation of thrombogenesis and ongoing fibrinolysis.

摘要

背景与目的

先前已证实中风患者存在止血异常。本研究旨在评估急性可逆性脑缺血时凝血系统特定参数的活性。

方法

我们测定了36例短暂性脑缺血发作(TIA)患者急性(<7天)和急性后期(1个月和3个月)的纤维蛋白肽A、凝血酶 - 抗凝血酶III及D - 二聚体。将结果与20例有既往TIA病史的无症状患者以及65例年龄和性别匹配的对照者的结果进行比较。

结果

与1个月时的水平相比,TIA后急性期的纤维蛋白肽A和凝血酶 - 抗凝血酶III的平均水平升高(P <.02)。相比之下,与既往TIA(P <.05)或对照者(P <.001)相比,事件发生后的所有三个时间点D - 二聚体均显著升高。通过双功超声评估,标志物水平与临床结局或颈部动脉粥样硬化程度之间未发现关联。

结论

这些发现表明,急性可逆性脑缺血后,存在血栓形成的早期短暂激活和持续的纤维蛋白溶解。

相似文献

1
Hemostatic markers in acute transient ischemic attacks.急性短暂性脑缺血发作中的止血标志物。
Stroke. 1994 Feb;25(2):282-6. doi: 10.1161/01.str.25.2.282.
2
Hemostatic markers in ischemic stroke of undetermined etiology.
Thromb Res. 1999 Nov 1;96(3):169-74. doi: 10.1016/s0049-3848(99)00097-3.
3
Hemostatic markers in patients at risk of cerebral ischemia.有脑缺血风险患者的止血标志物。
Stroke. 2000 Aug;31(8):1856-62. doi: 10.1161/01.str.31.8.1856.
4
Hemostasis activation markers in acute renal failure.
Ren Fail. 1998 Jan;20(1):147-55. doi: 10.3109/08860229809045097.
5
Hemostatic molecular markers in nephrotic syndrome.
Am J Hematol. 1993 Dec;44(4):276-9. doi: 10.1002/ajh.2830440411.
6
Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.孕期预防性给予抗凝血酶III可通过形成凝血酶-抗凝血酶III复合物,立即降低先天性抗凝血酶III缺乏症患者的凝血酶活性亢进。
Thromb Res. 1992 Jun 1;66(5):509-15. doi: 10.1016/0049-3848(92)90305-t.
7
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans.
Diabetologia. 1990 Mar;33(3):163-7. doi: 10.1007/BF00404044.
8
Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.使用水蛭素作为凝血酶 - 抗凝血酶复合物(TAT)形成抑制剂,对人血浆进行凝血酶孵育后,比较TAT水平和纤维蛋白肽A。
Thromb Res. 1991 Feb 1;61(3):253-9. doi: 10.1016/0049-3848(91)90101-2.
9
Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.通过止血分子标志物对心脏手术期间凝血酶原激活的特征分析。
Anesthesiology. 1994 Mar;80(3):520-6. doi: 10.1097/00000542-199403000-00007.
10
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.不稳定型心绞痛患者静脉输注特定凝血酶抑制剂4小时后出现凝血现象反弹的证据。
J Am Coll Cardiol. 1993 Apr;21(5):1039-47. doi: 10.1016/0735-1097(93)90222-m.

引用本文的文献

1
Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis.血浆凝血酶-抗凝血酶复合物对缺血性脑卒中的影响:系统评价和荟萃分析。
Syst Rev. 2023 Feb 14;12(1):17. doi: 10.1186/s13643-023-02174-9.
2
Biomarkers for Transient Ischemic Attack: A Brief Perspective of Current Reports and Future Horizons.短暂性脑缺血发作的生物标志物:当前报告与未来展望简述
J Clin Med. 2022 Feb 17;11(4):1046. doi: 10.3390/jcm11041046.
3
Characterization of a Temporal Profile of Biomarkers as an Index for Ischemic Stroke Onset Definition.
作为缺血性卒中发病定义指标的生物标志物时间谱特征分析。
J Clin Med. 2021 Jul 15;10(14):3136. doi: 10.3390/jcm10143136.
4
Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review.用于诊断短暂性脑缺血发作的候选生物标志物:系统评价。
Cerebrovasc Dis. 2019;47(5-6):207-216. doi: 10.1159/000502449. Epub 2019 Aug 30.
5
Identification of circulating microRNAs as potential biomarkers for detecting acute ischemic stroke.循环微RNA作为检测急性缺血性卒中潜在生物标志物的鉴定
Cell Mol Neurobiol. 2015 Apr;35(3):433-447. doi: 10.1007/s10571-014-0139-5. Epub 2014 Nov 20.
6
Transient ischemic attacks characterized by RNA profiles in blood.短暂性脑缺血发作的特征在于血液中的 RNA 谱。
Neurology. 2011 Nov 8;77(19):1718-24. doi: 10.1212/WNL.0b013e318236eee6. Epub 2011 Oct 12.
7
Blood biomarkers of ischemic stroke.缺血性脑卒中的血液生物标志物。
Neurotherapeutics. 2011 Jul;8(3):349-60. doi: 10.1007/s13311-011-0050-4.
8
Thrombin antithrombin complex and IL-18 serum levels in stroke patients.中风患者的凝血酶抗凝血酶复合物及白细胞介素-18血清水平
Neurol Int. 2010 Jun 21;2(1):e1. doi: 10.4081/ni.2010.e1.
9
Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events.血浆因子和抑制剂组成影响急性或既往脑血管事件患者的凝血酶生成动力学。
Thromb Res. 2010 Oct;126(4):262-9. doi: 10.1016/j.thromres.2010.07.002. Epub 2010 Aug 14.
10
Molecular biomarkers in stroke diagnosis and prognosis.中风诊断与预后中的分子生物标志物
Biomark Med. 2009 Aug 1;3(4):363-383. doi: 10.2217/bmm.09.30.